Jabil and HSE have formed a strategic collaboration to streamline the design, development, and scalable production of ...

U.S. Air Force Senior Airman Carol Ortiz, 355th Medical Support Squadron medical lab technician, prepares a COVID-19 sample kit at Davis-Monthan Air Force Base, Arizona, March 27, 2020. Medical staff ...

The Department of Health and Human Services is leading a virtual technology sprint to help automatically capture data from non-laboratory COVID-19 tests and report it to public health officials — an ...

Each step in a diagnostic test’s journey—from raw material extraction to patient administration—can influence outcomes. Advances in molecular biology, immunodiagnostics and rapid point-of-care (POC) ...

Collaboration combines leading expertise of Neuron23 in drug discovery, data science, and machine learning with QIAGEN's long-standing experience in companion diagnostic development Under the Master ...

OSLO, Norway--(BUSINESS WIRE)--NEC OncoImmunity AS (NOI), a subsidiary of NEC Corporation (NEC), and Oslo University Hospital (OUH) are pleased to announce that they have recently been awarded a ...

Biopharmaceutical major AstraZeneca plc (NASDAQ: AZN) recently revealed that it has signed a Master Collaboration Agreement with a molecular diagnostics company, Amoy Diagnostics Co. Ltd. Following ...

Each step in a diagnostic test’s journey—from raw material extraction to patient administration—can influence outcomes. Advances in molecular biology, immunodiagnostics and rapid point-of-care (POC) ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. At Illumina’s Genomics Forum conference this fall, former ...

Scientists have created a new technology that rapidly detects the SARS-CoV-2 virus. The new SENSR was developed using CRISPR gene-editing technology as a rapid diagnostic that eventually could be used ...

Earlier this year, up-and-coming biotech Neuron23 nominated its first clinical candidate, a small-molecule drug designed to inhibit the LRRK2 gene, mutations in which are commonly linked to inherited ...

FREEHOLD, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (ALBT), a developer of precision diagnostic consumer products, today announced that it entered into a definitive agreement with ...